| Business Summary | | Daxor
Corporation
is
a
medical
device
manufacturing
company
and
a
provider
of
biotech
services.
The
Company
was
originally
founded
for
cryobanking
services.
For
the
past
10
years,
the
Company's
major
focus
has
been
on
the
development
of
a
rapid,
accurate
instrument
to
measure
human
blood
volume.
The
Company
developed
an
instrument
called
the
BVA-100,
which
is
used
in
conjunction
with
a
single
use
diagnostic
injection
and
collection
kit. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Daxor
Corporation
is
engaged
in
the
development
and
marketing
of
cryopreservation
(freezing)
technology
for
human
semen
and
blood.
For
the
six
months
ended
6/30/01,
revenues
decreased
2%
to
$1.3
million.
Net
income
totalled
$134
thousand,
up
from
$32
thousand.
Revenues
suffered
from
a
decrease
in
gains
on
sale
of
securities
and
lower
sales
of
three
Blood
Volume
Analyzers.
Earnings
were
offset
by
a
decrease
in
selling,
general
and
administrative
expenses. | More
from
Market Guide: Significant
Developments |
| Officers | | | FY2000 Pay | |
| Joseph Feldschuh, M.D., 65 Chairman
and Pres | $184K | Ronald Baldry VP
of Engineering | 183K | Daniel Wellington VP | -- | Octavia Atanasiu Treasurer | -- | Virginia Fitzpatrick Corp.
Sec. | -- | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|